Clinical
Cerebro is used as a diagnostic service for life-threatening neurological infections in the state of Victoria, Australia.
Accreditation
Cerebro and the main sequencing assay will be undergoing accreditation at the Victorian Infectious Disease Reference Laboratory (VIDRL).
Development
Cerebro is developed as part of a national metagenomics diagnostic project (Meta-GP) funded by the Medical Research Future Fund (MRFF).
Analysis
Assay protocol and analysis pipeline implement best practices in the field of metagenomic pathogen detection.
Open-source
Code and assay protocols are open-source under the GNU GPL v3. Cerebro can be deployed in local networks for data privacy and security.
Research
Cerebro is implemented by a multi-disciplinary clinical research team at The Peter Doherty Institute for Infection and Immunity.